Manuscript

High p95HER2/HER2 ratio associated with poor outcome in Trastuzumab-treated HER2-positive metastatic breast cancer NCCTG N0337 and NCCTG 98-32-52 (Alliance)

March 1, 2018
  • Jeff Sperinde
  • Weidong Huang
  • Aki Vehtari
  • Ahmed Chenna
  • Pirkko-Liisa Kellokumpu-Lehtinen
  • John Winslow
  • Petri Bono
  • Yolanda S. Lie
  • Christos J. Petropoulos
  • Jodi Weidler
  • and Heikki Joensuu